• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90].

作者信息

Castaigne S, Archimbaud E, Fenaux P, Bordessoule D, Tilly H, Simon M, Dupriez B, Auzanneau G, Legros M, Tertian G

机构信息

Hôpital Saint-Louis, Paris, France.

出版信息

Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S139-40.

PMID:7971262
Abstract
摘要

相似文献

1
[Role of double induction in the treatment of acute myeloblastic leukemia in the adult: intermediate results of protocol LAM90].双重诱导在成人急性髓细胞白血病治疗中的作用：LAM90方案的中期结果
Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S139-40.
2
Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.米托蒽醌与阿糖胞苷诱导、大剂量阿糖胞苷以及依托泊苷强化治疗复发或难治性急性髓系白血病儿童患者：儿童癌症研究组2951研究
J Clin Oncol. 2003 Aug 1;21(15):2940-7. doi: 10.1200/JCO.2003.06.128.
3
[Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].[应用中等大剂量阿糖胞苷联合依托泊苷治疗对常规化疗耐药的急性髓系白血病的结果]
Pol Tyg Lek. 1988 Nov 21;43(47):1508-11.
4
Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia.序贯标准剂量米托蒽醌和阿糖胞苷用于新诊断的成人急性髓细胞白血病
Neoplasma. 1999;46(1):61-5.
5
Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.持续输注中等剂量阿糖胞苷、米托蒽醌联合依托泊苷治疗难治性或早期复发的急性髓系白血病。
Leuk Res. 2006 Feb;30(2):204-10. doi: 10.1016/j.leukres.2005.06.013. Epub 2005 Aug 1.
6
A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia.一项针对新诊断的急性髓细胞白血病患者，比较米托蒽醌持续输注与大剂量推注联合阿糖胞苷的随机试验。
Hematol Oncol. 2004 Jun;22(2):43-53. doi: 10.1002/hon.726.
7
Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.单剂量米托蒽醌联合持续输注中剂量阿糖胞苷加依托泊苷治疗难治性或早期复发的急性髓系白血病。
Leuk Res. 2009 Apr;33(4):511-7. doi: 10.1016/j.leukres.2008.08.009. Epub 2008 Sep 25.
8
Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.原发性耐药急性髓系白血病采用定时序贯化疗挽救治疗：预后因素分析
Ann Hematol. 2003 Nov;82(11):684-90. doi: 10.1007/s00277-003-0730-1. Epub 2003 Aug 19.
9
Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.含去甲氧柔红霉素的强化联合诱导方案治疗儿童急性髓细胞白血病的结果：阿根廷急性白血病治疗小组的初步报告
Semin Oncol. 1993 Dec;20(6 Suppl 8):34-8.
10
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.米托蒽醌、依托泊苷、阿糖胞苷联合环孢素治疗复发或难治性急性髓系白血病：东部肿瘤协作组的一项试点研究。
Cancer. 1999 Jan 15;85(2):358-67.